577 related articles for article (PubMed ID: 17533017)
1. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease.
Takei R; Ubara Y; Hoshino J; Higa Y; Suwabe T; Sogawa Y; Nomura K; Nakanishi S; Sawa N; Katori H; Takemoto F; Hara S; Takaichi K
Am J Kidney Dis; 2007 Jun; 49(6):744-52. PubMed ID: 17533017
[TBL] [Abstract][Full Text] [Related]
2. Intravascular embolization therapy in patients with enlarged polycystic liver.
Hoshino J; Ubara Y; Suwabe T; Sumida K; Hayami N; Mise K; Hiramatsu R; Hasegawa E; Yamanouchi M; Sawa N; Takei R; Takaichi K
Am J Kidney Dis; 2014 Jun; 63(6):937-44. PubMed ID: 24602778
[TBL] [Abstract][Full Text] [Related]
3. Treatment of symptomatic polycystic liver disease: transcatheter super-selective hepatic arterial embolization using a mixture of NBCA and iodized oil.
Wang MQ; Duan F; Liu FY; Wang ZJ; Song P
Abdom Imaging; 2013 Jun; 38(3):465-73. PubMed ID: 22743841
[TBL] [Abstract][Full Text] [Related]
4. Intravascular embolization therapy in a patient with an enlarged polycystic liver.
Ubara Y; Takei R; Hoshino J; Tagami T; Sawa N; Yokota M; Katori H; Takemoto F; Hara S; Takaichi K
Am J Kidney Dis; 2004 Apr; 43(4):733-8. PubMed ID: 15042552
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver.
Ubara Y
Ther Apher Dial; 2006 Aug; 10(4):333-41. PubMed ID: 16911186
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients.
Park HC; Kim CW; Ro H; Moon JY; Oh KH; Kim Y; Lee JS; Yin YH; Jae HJ; Chung JW; Ahn C; Hwang YH
J Korean Med Sci; 2009 Feb; 24(1):57-61. PubMed ID: 19270814
[TBL] [Abstract][Full Text] [Related]
7. Transarterial Embolization for Treatment of Symptomatic Polycystic Liver Disease: More than 2-year Follow-up.
Zhang JL; Yuan K; Wang MQ; Yan JY; Xin HN; Wang Y; Liu FY; Bai YH; Wang ZJ; Duan F; Fu JX
Chin Med J (Engl); 2017 Aug; 130(16):1938-1944. PubMed ID: 28776546
[TBL] [Abstract][Full Text] [Related]
8. Survival after arterial embolization therapy in patients with polycystic kidney and liver disease.
Hoshino J; Suwabe T; Hayami N; Sumida K; Mise K; Kawada M; Imafuku A; Hiramatsu R; Yamanouchi M; Hasegawa E; Sawa N; Takei R; Takaichi K; Ubara Y
J Nephrol; 2015 Jun; 28(3):369-77. PubMed ID: 25230989
[TBL] [Abstract][Full Text] [Related]
9. Pelvic insufficiency fracture related to autosomal dominant polycystic kidney disease.
Ubara Y; Higa Y; Tagami T; Suwabe T; Nomura K; Kadoguchi K; Hoshino J; Sawa N; Katori H; Takemoto F; Kitajima I; Hara S; Takaichi K
Am J Kidney Dis; 2005 Dec; 46(6):e103-11. PubMed ID: 16310561
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous treatment of pyocystis in patients with autosomal dominant polycystic kidney disease.
Akinci D; Turkbey B; Yilmaz R; Akpinar E; Ozmen MN; Akhan O
Cardiovasc Intervent Radiol; 2008; 31(5):926-30. PubMed ID: 18196333
[TBL] [Abstract][Full Text] [Related]
11. Volume Reduction in Enlarged Kidneys in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Prior to Renal Transplant with Transcatheter Arterial Embolization (TAE): A Systematic Review and Meta-Analysis.
Ye W; Voss MD; Athreya S
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):828-834. PubMed ID: 29388019
[TBL] [Abstract][Full Text] [Related]
12. Repetitive Refractory Renal Cyst Infection in Autosomal Dominant Polycystic Kidney Disease for which Renal Transcatheter Arterial Embolization Was Effective in Preventing Recurrence.
Suwabe T; Oguro M; Ubara Y; Ikuma D; Mizuno H; Hayami N; Yamanouchi M; Sawa N
Intern Med; 2021; 60(20):3261-3265. PubMed ID: 34657906
[TBL] [Abstract][Full Text] [Related]
13. Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease.
Suwabe T; Ubara Y; Higa Y; Nakanishi S; Sogawa Y; Nomura K; Nishimura H; Hoshino J; Sawa N; Katori H; Takemoto F; Nakamura M; Tomikawa S; Hara S; Takaichi K
Nephron Clin Pract; 2009; 112(3):c157-63. PubMed ID: 19390216
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with the use of tris-acryl gelatin microspheres for transcatheter arterial embolization for enlarged polycystic liver.
Sakuhara Y; Nishio S; Hattanda F; Soyama T; Takahashi B; Abo D; Mimura H
Clin Exp Nephrol; 2019 Jun; 23(6):825-833. PubMed ID: 30771042
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease.
Fukasawa H; Kaneko M; Niwa H; Yasuda H; Kumagai H; Furuya R
Nephrology (Carlton); 2018 Mar; 23(3):210-216. PubMed ID: 28024168
[TBL] [Abstract][Full Text] [Related]
16. Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial.
Gevers TJ; Hol JC; Monshouwer R; Dekker HM; Wetzels JF; Drenth JP
Liver Int; 2015 May; 35(5):1607-14. PubMed ID: 25369108
[TBL] [Abstract][Full Text] [Related]
17. Sleep-Disordered Breathing in Patients with Polycystic Liver and Kidney Disease Referred for Transcatheter Arterial Embolization.
Sumida K; Hoshino J; Suwabe T; Kasai T; Hayami N; Mise K; Kawada M; Imafuku A; Hiramatsu R; Hasegawa E; Yamanouchi M; Sawa N; Narui K; Takaichi K; Ubara Y
Clin J Am Soc Nephrol; 2015 Jun; 10(6):949-56. PubMed ID: 25825485
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
Bae KT; Zhu F; Chapman AB; Torres VE; Grantham JJ; Guay-Woodford LM; Baumgarten DA; King BF; Wetzel LH; Kenney PJ; Brummer ME; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2006 Jan; 1(1):64-9. PubMed ID: 17699192
[TBL] [Abstract][Full Text] [Related]
19. Comparison of MRI segmentation techniques for measuring liver cyst volumes in autosomal dominant polycystic kidney disease.
Farooq Z; Behzadi AH; Blumenfeld JD; Zhao Y; Prince MR
Clin Imaging; 2018; 47():41-46. PubMed ID: 28846875
[TBL] [Abstract][Full Text] [Related]
20. Autosomal Dominant Polycystic Kidney Disease in which the Polycystic Liver Volume Was Reduced by Rigorous Blood Pressure Control.
Suwabe T; Ubara Y; Ikuma D; Mizuno H; Hayami N; Yamanouchi M; Sawa N
Intern Med; 2022 Jan; 61(1):49-52. PubMed ID: 34219109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
